HBIO Q1 2026 Earnings EPS Surprises to the Upside Despite Challenging Quarter PMV Pharmaceuticals PMVP Q1 2026 Earnings Narrower Loss Provides a Glimmer of Operational Efficiency PG Q1 2026 Earnings EPS Misses Estimates Amid Mixed Operational Performance Gossamer Bio Q1 2026 Earnings WiderThanExpected Loss as No Revenue Generated GAING Q1 2026 Earnings EPS Misses Estimates as Net Investment Income Falls Short MCK Q1 2026 Earnings EPS Beats Estimates by a Narrow Margin